Health Canada considers bamlanivimab and etesevimab combination for COVID-19 IV monoclonal antibodies recently received US Emergency Use Authorization for treatment of mild to moderate COVID-19 in high-risk outpatients. Health Canada approves AstraZeneca's COVID-19 vaccine Doctors, caregivers push for in home COVID-19 vaccinations for housebound senior Small group of Ontario pharmacies to do 'dry run' ahead of participation in vaccine rollout A career re-boot in pharmacy IT Canada's 'long haulers' without family doctor need primary care: CMA Overview of recent oral oncology drugs An overview of new oral targeted cancer therapies for community pharmacists HEPA filters, focus on ventilation can help open economy Pay-for-plasma company to expand into Alberta after ban lifted Strategic antibody tests touted as tool in road to achieving broad COVID immunity First Previous 93 94 95 96 97 Next Last
